25 hydroxy-vitamin D3-1α hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone

Journal of Steroid Biochemistry and Molecular Biology

Volumn 107, Issue 3-5, 2007, Pages 238-244

  Somjen, Dalia ^a   Katzburg, Sara ^a   Stern, Naftali ^a   Kohen, Fortune ^c   Sharon, Orly ^a   Limor, Rona ^a   Jaccard, Niva ^b   Hendel, David ^d   Weisman, Yosef ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Estrogens; Hydroxylase; Osteoblasts; Phytoestrogens; Vitamin D

Indexed keywords

ANDROSTANOLONE; BIOCHANIN A; CALCIDIOL 1 MONOOXYGENASE; ESTRADIOL; ESTROGEN; GENISTEIN; PARATHYROID HORMONE; RALOXIFENE;

ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; OSTEOBLAST; PARACRINE SIGNALING; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; BASE SEQUENCE; CELLS, CULTURED; DIHYDROTESTOSTERONE; DNA PRIMERS; ESTROGENS; HUMANS; OSTEOBLASTS; PARATHYROID HORMONE; RNA, MESSENGER;

EID: 34548488946     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.03.048     Document Type: Article

References (42)

1. Feldman D., Malloy P.J., Goldschmidt D., and Gross C. Vitamin D: biology, action and clinical implications. In: Marcus R., Feldman D., and Kelsey J. (Eds). Osteoporosis vol. 1 (2001), Academic Press, San Diego, CA, USA pp. 257-230
2. 3-1alpha-hydroxylase in the human kidney. J. Am. Soc. Nephrol. 10 (1999) 2465-2473
3. 3-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 86 (2001) 888-894
4. 3 in vitro synthesis by human decidua and placenta. Nature 281 (1979) 317-319
5. Pillai S., Bikle D.D., and Elias P.M. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J. Biol. Chem. 263 (1988) 5390-5395
6. 3 by normal human macrophages. Biochem. Biophys. Res. Commun. 127 (1985) 596-603
7. Holick M.F. Prostatic 25-hydroxy vitamin D-1-alpha-hydroxylase and its implication in prostate cancer. J. Cell. Biochem. 88 (2003) 315-322
8. Tangpricha V., Flanagan J.N., Whitlatch L.W., Tseng C.C., Chen T.C., Holt P.R., Lipkin M.S., and Holick M.F. 25-Hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 357 (2001) 1673-1674
9. Zehnder D., Bland R., Chana R.S., Wheeler D.C., Howie A.J., Williams M.C., Stewart P.M., and Hewison M. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J. Am. Soc. Nephrol. 13 (2002) 621-629
10. 3-1α-hydroxylase is expressed in human vascular smooth muscle cells and is up regulated by parathyroid hormone and estrogenic compounds. Circulation 111 (2005) 1666-1671
11. 3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. Endocrinology 125 (1989) 327-333
12. Price P.A. Role of vitamin-K-dependent proteins in bone metabolism. Annu. Rev. Nutr. 8 (1988) 565-583
13. Suda T., Ueno Y., Fujii K., and Shinki T. Vitamin D and bone. J. Cell. Biochem. 88 (2003) 259-266
14. 3 on the expression of DNA replication genes. J. Bone Miner. Res. 19 (2004) 133-146
15. Turner R.T., Puzas J.E., Forte M.D., Lester G.E., Gray T.K., Howard G.A., and Baylink D.J. In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 5720-5724
16. 3. J. Biol. Chem. 256 (1981) 7738-7740
17. Katzburg S., Lieberherr M., Ornoy A., Klein B.Y., Hendel D., and Somjen D. Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: gender and age differences. Bone 25 (1999) 667-673
18. Limor R., Weisinger G., Gilad S., Knoll E., Sharon O., Jaffe A., Kohen F., Berger E., Lifschizt-Mercer B., and Stern N. A novel form of platelet-type 12-lipoxygenase mRNA in human vascular smooth muscle cells. Hypertension 38 (2000) 864-871
19. Somjen D., Amir-Zaltsman Y., Gayer B., Kulik T., Knoll E., Stern N., Lu L.J., Toldo L., and Kohen F. 6-Carboxymethyl genistein: a novel selective oestrogen receptor modulator (SERM) with unique, differential effects on the vasculature, bone and uterus. J. Endocrinol. 173 (2002) 415-427
20. Somjen D., Kohen F., Gayer B., Sharon O., Baz M., Limor R., Kulik T., Knoll E., and Stern N. Role of putative membrane receptors in the effects of estradiol on human vascular cell growth. Am. J. Hypertens. 17 (2004) 462-469
21. Fu K.G., Lin D., Zhang M.Y.H., Bikle D.D., Shackleton C.H.L., Miller W.L., and Portala A.A. Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type I. Mol. Endocrinol. 11 (1977) 1961-1970
22. 3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J. Clin. Endocrinol. Metab. 64 (1987) 1-9
23. 3 by interferon-γ-stimulated normal human bone marrow and alveolar macrophages. J. Biol. Chem. 262 (1987) 10931-10937
24. Pryke A.M., Duggan C., White C.P., Posen S., and Mason R.S. Tumour necrosis factor-α induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages. J. Cell. Physiol. 142 (1990) 652-656
25. Bikle D.D., Pillai S., Gee E., and Hincenbergs M. Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 124 (1989) 655-660
26. Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13 (1992) 719-764
27. Hewison M., and O'Riordan J.L.H. Immunomodulatory and cell differentiation effects of vitamin D. In: Feldman D., Glorieux F.H., and Pike J.W. (Eds). Vitamin D (1997), Academic Press, San Diego pp. 447-462
28. 3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J. Biol. Chem. 280 (2005) 14130-14137
29. 3-1 alpha gene promoter. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 1387-1391
30. 3. Arch. Biochem. Biophys. 381 (2000) 143-152
31. Young M.W., Schwartz G.G., Wang L., Jamieson D.P., Whitlatch L.W., Flangan J.M., Lokeshwar B.L., Holick M.F., and Chen T.C. The prostate 25-hydroxy vitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium; implication for prostate cancer chemoprevention by vitamin D. Carcinogenesis 25 (2004) 967-971
32. Williams P.J., Brain D.C., Peddie N.J., and Taylor T.G. Effects of estrone and estradiol-17β on 25-hydroxy cholecalcyferol hydroxylase activities in female Japanese quail. Gen. Comp. Endocrinol. 7 (1988) 97-104
33. 3-1 alpha-hydroxylase by estrogen. Arch. Biochem. Biophys. 179 (1977) 211-217
34. Cheema C., Grant B.F., and Marcus R. Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women. J. Clin. Inves. 83 (1989) 537-542
35. Aarskog D., Aksnes L., Markestad T., and Rodland O. Effect of estrogen on vitamin D metabolism in tall girls. J. Clin. Endocrinol. Metab. 57 (1983) 1155-1158
36. Kallay E., Adlercreutz H., Farhan H., Lechner D., Bajna E., Gerdenitsch W., Campbell M., and Cross H.S. Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumour prevention and therapy. J. Nutr. 132 (2002) 3490S-3493S
37. Cross H.S., Kallay E., Lechner D., Gerdenitsch W., Adlercreutz H., and Armbrecht H.J. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J. Nutr. 134 (2004) 1207S-1212S
38. Manolagas S.C., Kousteni S., and Jilka R.L. Sex steroids and bone. Recent Prog. Horm. Res. 57 (2002) 385-409
39. Qin L., Raggatt L.J., and Partridge N.C. Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol. Metab. 15 (2004) 60-65
40. Vanderschueren D., Vandenput L., Boonen S., Lindberg M.K., Bouillon R., and Ohlsson C. Androgens and bone. Endocr. Rev. 25 (2004) 389-425
41. 2-2 (JKF). J. Steroid Biochem. Mol. Biol. 98 (2006) 139-146
42. D. Somjen, G.H. Posner, Y. Weisman, A.M. Kaye, Less-calcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in the rat skeletal tissues, J. Endocr. Invest., in press.